Augmented Th17 differentiation in Trim21 deficiency promotes a stable phenotype of atherosclerotic plaques with high collagen content
- 4 September 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 114 (1) , 158-167
Abstract
Patients with hyperlipidemia are at risk of atherosclerosis, but not all develop cardiovascular disease, highlighting the importance of other risk factors such as inflammation. Both the innate and adaptive arms of the immune system have been suggested in the initiation and propagation of plaque formation. Tri-partite motif (TRIM) 21 is a regulator of tissue inflammation and pro-inflammatory cytokine production, and has been implicated in chronic inflammatory disease. Here, we investigate a potential role for TRIM21 in coronary artery disease. Trim21-deficient or wild-type bone marrow was transplanted into Ldlr-/- mice fed a hypercholesterolemic diet. The Trim21-/-->Ldlr-/- mice developed larger atherosclerotic plaques, with significantly higher collagen content compared to mice transplanted with wild-type cells. High collagen content of the atheroma is stabilizing, and has recently been linked to IL-17. Interestingly, Trim21-/-->Ldlr-/- mice had elevated CD4 and IL-17 mRNA expression in plaques, and increased numbers of activated CD4+ T cells in the periphery. An increased differentiation of naïve T cells lacking Trim21 into Th17 cells was confirmed in vitro, with transcriptomic analysis revealing upregulation of genes of a non-pathogenic Th17 phenotype. Also, decreased expression of matrix metalloproteinases (MMPs) was noted in aortic plaques. Analysis of human carotid plaques confirmed that TRIM21 expression negatively correlates with the expression of key Th17 genes and collagen, but positively to MMPs also in patients, linking our findings to a clinical setting. In this study, we demonstrate that TRIM21 influences atherosclerosis via regulation of Th17 responses, with TRIM21 deficiency promoting IL-17 expression and a more fibrous, stable, phenotype of the plaques.Keywords
This publication has 45 references indexed in Scilit:
- A Validated Regulatory Network for Th17 Cell SpecificationCell, 2012
- Induction and molecular signature of pathogenic TH17 cellsNature Immunology, 2012
- Control of TH17 cells occurs in the small intestineNature, 2011
- Macrophages in the Pathogenesis of AtherosclerosisCell, 2011
- Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosisJournal of Experimental Medicine, 2010
- Complex Regulation and Function of the Inflammatory Smooth Muscle Cell Phenotype in AtherosclerosisJournal of Vascular Research, 2009
- Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosisJournal of Experimental Medicine, 2009
- Ro52-mediated Monoubiquitination of IKK Down-regulates NF- B SignallingThe Journal of Biochemistry, 2009
- Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23–Th17 pathwayJournal of Experimental Medicine, 2009
- PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage AnalysesThe American Journal of Human Genetics, 2007